Liuqing Xu
发表
S. Zhuang,
Yingfeng Shi,
Liuqing Xu,
2019,
American journal of physiology. Renal physiology.
Yan Wu,
Liuqing Xu,
Changming Zhou,
2021,
Integrative cancer therapies.
Tao Yang,
S. Zhuang,
Y. E. Chin,
2015,
Journal of the American Society of Nephrology : JASN.
Xiaoqiang Ding,
S. Zhuang,
Yingfeng Shi,
2017,
Oncotarget.
S. Zhuang,
Yingfeng Shi,
Liuqing Xu,
2018,
Clinical science.
Nintedanib, a triple tyrosine kinase inhibitor, attenuates renal fibrosis in chronic kidney disease.
F. Liu,
S. Zhuang,
Hualin Qi,
2017,
Clinical science.
S. Zhuang,
Yingfeng Shi,
Liuqing Xu,
2017,
American journal of physiology. Renal physiology.
S. Zhuang,
H. Mao,
Yingfeng Shi,
2015,
Journal of the American Society of Nephrology : JASN.
S. Zhuang,
Yingfeng Shi,
Liuqing Xu,
2017,
Oncotarget.
S. Zhuang,
Liuqing Xu,
A. Qiu,
2019,
Cell Death & Disease.
S. Zhuang,
Yingfeng Shi,
Liuqing Xu,
2017,
Journal of diabetes research.
S. Zhuang,
Jing Nie,
Yingfeng Shi,
2017
.
S. Zhuang,
Yingfeng Shi,
Liuqing Xu,
2017,
Oncotarget.
Wei Tang,
L. Bao,
Bin Zhou,
2019,
Cell Research.
F. Liu,
S. Zhuang,
Hualin Qi,
2017,
Oncotarget.